MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-01-0071854
Sankur Pharmaceuticals Private Limited - pharma in Agra, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹12.67 Cr
▲ 22% YoY
Net profit · FY 2024
₹26.24 Lakh
Net margin 2.1%
EBITDA · FY 2024
₹51.19 Lakh
EBITDA margin 4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹40 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Sankur Pharmaceuticals Private Limited
Data last updated:
Sankur Pharmaceuticals Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2016PTC076748. Its GSTIN is 09AAWCS8845A1ZR (Uttar Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Chirayush Singhal and Deepak Kumar Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at F – 648 Kamla Nagar, Agra, Uttar Pradesh, India – 282005.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.67 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹26.24 Lakh (net margin 2.1%) and EBITDA of ₹51.19 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over five years.
The company is associated with 1 brand: Sankur Pharmaceuticals. As per MCA filings, the company has open charges of ₹40 Lakh on record.
Sankur Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-01-0071854). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sankurpharma.com.
Company details
CIN U74120UP2016PTC076748
Registration Number 076748
Incorporation Date 23 February 2016
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-01-0071854
Recognitions & Rankings of Sankur Pharmaceuticals
Contact details
Sankur Pharmaceuticals Private Limited's registered office is in Agra, Uttar Pradesh. Its website is sankurpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF – 648 Kamla Nagar, Agra, Uttar Pradesh, India – 282005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sankur Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sankur Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sankur Pharmaceuticals operates one associated brand: Sankur Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of veterinary pharmaceuticals and feed supplements for animal health. | sankurpharma.com |
Business activity
The main business activity of Sankur Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sankur Pharmaceuticals Private Limited, buy the company report.
Financials of Sankur Pharmaceuticals Private Limited
FY 2024 filings availableSankur Pharmaceuticals Private Limited reported revenue of ₹12.67 Cr (up 22% YoY) for FY 2024.
Revenue · FY 2024
₹12.67 Cr ▲ 22%
Net profit · FY 2024
₹26.24 Lakh margin 2.1%
EBITDA · FY 2024
₹51.19 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 78%
3 years · compounded
▲ 1%
5 years · compounded
▲ 35%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 22% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sankur Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sankur Pharmaceuticals Private Limited
Sankur Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chirayush Singhal Also directs: Envirobrace Sustainable Solutions Private Limited | Director | 23 Feb 2016 | 10 Years 8 Months | Current |
| Deepak Kumar Agarwal | Director | 23 Feb 2016 | 10 Years 8 Months | Current |
Peer comparison
Sankur Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thaiger Pharma Private Limited | ₹12.77 Cr (FY 2025) | -15.0% | Mumbai, Maharashtra, India | |||
| Soft Touch Pharmaceutical India Limited | ₹12.75 Cr (FY 2025) | 14.0% | Solan, Himachal Pradesh, India | |||
| Shalman Pharmaceuticals Private Limited | ₹12.73 Cr (FY 2024) | -3.0% | Vadodara, Gujarat, India | |||
| Reallab Biotech Private Limited | ₹12.68 Cr (FY 2025) | 23.0% | Meerut, Uttar Pradesh, India | |||
| Sankur Pharmaceuticals Private Limitedthis company | ₹12.67 Cr (FY 2024) | ₹26.24 Lakh | 2.1% | 22.0% | Agra, Uttar Pradesh, India | |
| Totus Health Care (India) Limited | ₹12.64 Cr (FY 2019) | 23.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sankur Pharmaceuticals Private Limited, buy the company report.
Auditor
Sankur Pharmaceuticals Private Limited is audited by RAJESH GARG & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESH GARG & CO. | FY 2023 | 004910C |
Shareholding
The shareholding of Sankur Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sankur Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 May 2023 | 100729229 | Axis Bank Limited | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sankur Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Sankur Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 6 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sabari Chemicals Private Limited | |||
| S L D Packaging | |||
| G Nine Bioceuticals Private Limited | |||
| an individual supplier | |||
| Standard Analytical Laboratory N D Private Limited |
To see the full MSME payment records of Sankur Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Sankur Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAWCS8845A1ZR | Uttar Pradesh | Active | 01 Jul 2017 |
| 05AAWCS8845A1ZZ | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sankur Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sankur Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Chirayush Singhal was appointed as Director on 23 Feb 2016.
AGM
Sankur Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sankur Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Charges
A charge with Axis Bank Limited amounted to Rs. 40.00 Lakh with Charge ID 100729229 was registered on 22 May 2023.
Appointed
Chirayush Singhal was appointed as Director.
Appointed
Deepak Kumar Agarwal was appointed as Director.
Incorporation
23 Feb 2016
Sankur Pharmaceuticals Private Limited was registered on 23 Feb 2016 with Roc Kanpur & aged 10 years 8 months as per MCA records.
Frequently asked questions
Sankur Pharmaceuticals is an active private limited company based in Agra, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 February 2016 (10+ years old) and is registered under CIN U74120UP2016PTC076748.
Sankur Pharmaceuticals has 2 current directors:
- Chirayush Singhal - Director
- Deepak Kumar Agarwal - Director
The latest financial statements of Sankur Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sankur Pharmaceuticals is 09AAWCS8845A1ZR, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAWCS8845A1ZZ (Uttarakhand).
The CIN (Corporate Identification Number) of Sankur Pharmaceuticals is U74120UP2016PTC076748. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sankur Pharmaceuticals was incorporated on 23 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Sankur Pharmaceuticals by revenue are Thaiger Pharma Private Limited, Soft Touch Pharmaceutical India Limited, Shalman Pharmaceuticals Private Limited, Reallab Biotech Private Limited, Totus Health Care (India) Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chirayush Singhal was appointed as Director on 23 Feb 2016. Deepak Kumar Agarwal was appointed as Director on 23 Feb 2016.
Yes, Sankur Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UP-01-0071854).
Sankur Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 6 overdue payments to 6 micro and small suppliers. The latest return was filed on 08 Jun 2019.
Sankur Pharmaceuticals can be reached through the website sankurpharma.com. Its registered office is in Agra, Uttar Pradesh, India.
The registered office of Sankur Pharmaceuticals is at F – 648 Kamla Nagar, Agra, Uttar Pradesh, India – 282005.